Loading…
Lobbying Spend
—
Filings
20
Firms Hired
2
Active Period
2022–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Maintaining Investments in New Innovation Act
2026 · third_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care; Legislation includes the Safe Step Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); Womens Heart Health Expansion Act of 2026 (H.R. 7417/S; 3944); and Cardiovascular Disease Early Detection and Prevention Act (H.R. 8260).
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1672
Women’s Heart Health Expansion Act of 2026
2026 · third_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care; Legislation includes the Safe Step Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); Womens Heart Health Expansion Act of 2026 (H.R. 7417/S; 3944); and Cardiovascular Disease Early Detection and Prevention Act (H.R. 8260).
Client expense: — · Firm income: $15,000
Matched citations: H.R. 7417
Cardiovascular Disease Early Detection and Prevention Act of 2026
2026 · third_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care; Legislation includes the Safe Step Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); Womens Heart Health Expansion Act of 2026 (H.R. 7417/S; 3944); and Cardiovascular Disease Early Detection and Prevention Act (H.R. 8260).
Client expense: — · Firm income: $15,000
Matched citations: H.R. 8260
Maintaining Investments in New Innovation Act
2026 · second_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care; Legislation includes the Safe Step Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); Womens Heart Health Expansion Act of 2026 (H.R. 7417/S; 3944); and Cardiovascular Disease Early Detection and Prevention Act (H.R. 8260).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1672
Women’s Heart Health Expansion Act of 2026
2026 · second_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care; Legislation includes the Safe Step Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); Womens Heart Health Expansion Act of 2026 (H.R. 7417/S; 3944); and Cardiovascular Disease Early Detection and Prevention Act (H.R. 8260).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7417
Cardiovascular Disease Early Detection and Prevention Act of 2026
2026 · second_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care; Legislation includes the Safe Step Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); Womens Heart Health Expansion Act of 2026 (H.R. 7417/S; 3944); and Cardiovascular Disease Early Detection and Prevention Act (H.R. 8260).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8260
Maintaining Investments in New Innovation Act
2026 · first_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care. Legislation includes the Safe Step Act and the Accelerating Kids Access to Care Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); and Womens Heart Health Expansion Act of 2026 (H.R. 7417/S. 3944).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1672
Women’s Heart Health Expansion Act of 2026
2026 · first_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care. Legislation includes the Safe Step Act and the Accelerating Kids Access to Care Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); and Womens Heart Health Expansion Act of 2026 (H.R. 7417/S. 3944).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7417
Women’s Heart Health Expansion Act of 2026
2026 · first_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care. Legislation includes the Safe Step Act and the Accelerating Kids Access to Care Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); and Womens Heart Health Expansion Act of 2026 (H.R. 7417/S. 3944).
Client expense: — · Firm income: $60,000
Matched citations: S. 3944
Maintaining Investments in New Innovation Act
2025 · fourth_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care. Legislation includes the Safe Step Act and the Accelerating Kids Access to Care Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, and Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1672
Maintaining Investments in New Innovation Act
2025 · third_quarter · Firm: TROUTMAN STATEGIES
Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care. Legislation includes the Safe Step Act and the Accelerating Kids Access to Care Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, and Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1672
Cardiovascular Advances in Research and Opportunities Legacy Act
2022 · fourth_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: H.R. 1193
Newborn Screening Saves Lives Reauthorization Act of 2021
2022 · fourth_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: H.R. 482
Cardiovascular Advances in Research and Opportunities Legacy Act
2022 · fourth_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: S. 1133
Newborn Screening Saves Lives Reauthorization Act of 2021
2022 · fourth_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: S. 350
Cardiovascular Advances in Research and Opportunities Legacy Act
2022 · third_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: H.R. 1193
Newborn Screening Saves Lives Reauthorization Act of 2021
2022 · third_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: H.R. 482
Cardiovascular Advances in Research and Opportunities Legacy Act
2022 · third_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: S. 1133
Newborn Screening Saves Lives Reauthorization Act of 2021
2022 · third_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: —
Matched citations: S. 350
Cardiovascular Advances in Research and Opportunities Legacy Act
2022 · second_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: $47,000
Matched citations: H.R. 1193
Newborn Screening Saves Lives Reauthorization Act of 2021
2022 · second_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: $47,000
Matched citations: H.R. 482
Cardiovascular Advances in Research and Opportunities Legacy Act
2022 · second_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: $47,000
Matched citations: S. 1133
Newborn Screening Saves Lives Reauthorization Act of 2021
2022 · second_quarter · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Client expense: — · Firm income: $47,000
Matched citations: S. 350
Cardiovascular Advances in Research and Opportunities Legacy Act
2022 · second_quarter · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Client expense: — · Firm income: —
Matched citations: H.R. 1193
Newborn Screening Saves Lives Reauthorization Act of 2021
2022 · second_quarter · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Client expense: — · Firm income: —
Matched citations: H.R. 482
Source: Senate LDA